Blue Sky...for new Marijuana play...
XXII...the New "Safe" Medical Marijuana solution. Rocket just taking off.
Marijuana has 3x as much Carcinogens as Smoking Tobacco. With FDA getting even tougher on Tars(carcinogens) and nicotine in regular tobacco...
How long will it take for the FDA to wake up to a more deadly product that is inhaled deeper into the lungs and exacerbates the problem of cigarette smokers who also use marijuana.
XXII is a biotech company with over 135 national and international patents that specializes in engineering tobacco plant seeds to grow VLN and VLT (very low tars) tobacco leaves/cigarettes. They appear to now be using their technology to engineer VLT Marijuana plant seeds for the Medical Marijuana industry.
They have British Tobacco as their partner (with a $14 million dollar commitment, half paid)just to "research" their tobacco technology. They are about to launch a premium cigarette in U.S., and have already launched in E.U (VLN)
Having just purchased a $3.2M cigarette plant in NC (all cash) and having the FDA finance a phase II study on their VLN an VLT cigarettes to promulgate rules on advertising VLN and VLT...as well as Pfizer doing its own study with XXII's proprietary cigarettes, in conjunction with smoke cessation...this company is about to DISRUPT the $700 Billion dollar Tobacco industry and is on the launch pad.
Now, it is apparent that word is leaking out and IMHO, will soon be announced about their working on marijuana engineering for a "safer" marijuana plant. Stock is about to be uplisted to NYSE or Nasdaq anyday (per press releases and 10K)...and as soon as next week.
The additional Marijuana play is not to be overlooked, and apparently it is not.
Having almost doubled to $4.21 at weeks end, with no debt and over $4M in cash about to uplist, and a relatively small issuance and float (53M/35M), IMHO it will be ripe for institutional purchasing upon Uplisting and a move to $5...at which point it can also be (and might be required to be) purchased by the index fund, resulting in further upside to its $200M market cap. IMHO...its a $20 stock in 6 months (if not sooner) and multiples of that upon further execution of its business plan.
